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ABSTRACT Protein misfolding and aggregation are interconnected processes involved in a wide variety of nonneuropathic,
systemic, and neurodegenerative diseases. More generally, if mutations in sequence or changes in environmental conditions
lead to partial unfolding of the native state of a protein, it will often aggregate, sometimes into well-deﬁned ﬁbrillar structures. A
great deal of interest has been directed at discovering the characteristic features of metastable partially unfolded states that
precede the aggregated states of proteins. In this work, human muscle acylphosphatase (AcP) has been ﬁrst destabilized, by
addition of urea or by means of elevated temperatures, and then incubated in the presence of different concentrations of 2,2,2,
triﬂuoroethanol ranging from 5% to 25% (v/v). The results show that AcP is able to form both ﬁbrillar and nonﬁbrillar aggregates
with a high b-sheet content from partially unfolded states with very different structural features. Moreover, the presence of
a-helical structure in such a state does not appear to be a fundamental determinant of the ability to aggregate. The lack of ready
aggregation under some of the conditions examined here is attributable primarily to the intrinsic properties of the solutions rather
than to speciﬁc structural features of the partially unfolded states that precede aggregation. Aggregation appears to be favored
when the solution conditions promote stable intermolecular interactions, particularly hydrogen bonds. In addition, the structures
of the resulting aggregates are largely independent of the conformational properties of their soluble precursors.
INTRODUCTION
Many systemic and neurodegenerative disorders, from light
chain amyloidosis to Alzheimer’s disease, have been found
to be associated with the misfolding and aggregation of
speciﬁc proteins (1–3). There are thought to be two primary
origins of the pathogenic behavior associated with these
disorders: organ damage resulting from deposition of large
amounts of ﬁbrillar aggregates (4), generally called amyloid
ﬁbrils or plaques, and cellular dysfunction resulting from the
interactions of small, perhaps nonﬁbrillar aggregates with
plasma membranes and other cellular and extracellular
components (2,5,6). Importantly, the latter species appear,
at least in many cases, to represent the precursors of amyloid
ﬁbril formation (1,7,8).
Despite a lack of identiﬁable common features in the
sequences and structures of the proteins implicated in the
different amyloid diseases, the ﬁbrillar aggregates associated
with them are all characterized by a high degree of structural
order and a high intermolecular b-sheet content (9–11). It
has therefore been postulated that there is a common un-
derlying mechanism of formation of the various ﬁbrillar
aggregates (1). Moreover, an increasing body of evidence
supports the ‘‘generic hypothesis’’ that the ability to form
amyloid structures with ordered intermolecular b-sheets is
an inherent property of polypeptide chains and therefore that
all proteins, at least in principle, have the potential to form
such structures under appropriate conditions (1,10,12–14).
The soluble precursors of amyloid aggregates can be either
globular proteins, or their fragments, or natively unfolded
polypeptides (15). Globular proteins generally need to be
destabilized (e.g., by mutation (16–20), heat (21,22), high
pressure (23,24), low pH (25,26), or organic denaturant
(13,21)) to aggregate rapidly, with ﬁbril formation pro-
ceeding either from extensively or partially unfolded states
(1,15) or, in some cases, from native-like states in which un-
folding may initially be limited and conﬁned to local regions
of the protein (27–30). By contrast, natively unfolded pro-
teins expose large portions of their polypeptide chains to
solvent so that aggregation, under conditions favoring inter-
molecular interactions, can occur without the prerequisite of
a major conformational change (15).
A great deal of attention has recently been focused on the
structural characteristics of the conformational states popu-
lated under conditions where aggregation occurs and on the
factors that promote the conversion of these precursor states
into aggregates (15,31–39). Electrostatic repulsion, hydro-
phobicity, and secondary structure propensity have all been
shown to have a major inﬂuence on the tendency of fully or
partially unfolded proteins to aggregate (35). Interesting
issues in such studies are whether a high population of a
speciﬁc conformation in denatured states is required for the
efﬁcient generation of amyloid ﬁbrils and whether or not
differences in the morphologies of the resulting ﬁbrils are
associated with differences in the structures and properties of
the precursor states (34). Several studies have highlighted the
fact that partially folded states containing a-helical structure
are highly populated under conditions in which amyloid
formation occurs, and indeed in some cases it is only at later
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stages of the aggregation process that large-scale conversion
to b-sheet structure takes place (40–45). In addition, it has
been found that, depending on solution conditions, the pres-
ence of a-helical structure in partially folded states can
promote the formation of ﬁbrils as well as inhibit it (43). In
other cases, however, it appears that aggregation involves the
interaction between solvent-exposed and ﬂexible regions
that lack stable hydrogen-bonded elements of secondary
structure, i.e., from highly unfolded polypeptide segments
that can readily form b-sheet structure (18,22,39). Finally, as
mentioned above, several recent studies show that in some
cases aggregation can be initiated from highly native-like states
before major conformational rearrangements (27–30,41).
To investigate further the relevance of the quantity and
type of residual structure in the unfolded or partially un-
folded states from which the aggregation process takes place,
we have studied the effects of the nature of partially unfolded
conformations, obtained under a range of conditions, on the
aggregation behavior of human muscle acylphosphatase
(AcP). AcP is a small globular protein shown to form ﬁbril-
lar aggregates after partial unfolding in 25% (v/v) 2,2,2
triﬂuoroethanol (TFE) (13), a solvent that has been found
also to promote aggregation of other polypeptides (46–50),
including the natively unfolded Ab-peptide (43). The re-
sulting ﬁbrils have a high content of b-sheet structure, bind
to thioﬂavin T (ThT), and display apple-green birefringence
in the presence of Congo red under cross-polarized light
(13); this set of properties is highly characteristic of amyloid
structures. In a variety of studies, TFE has been shown to
stabilize hydrogen bonds but at the same time to weaken hy-
drophobic interactions (51–54). Different concentrations of
TFE are therefore expected to give rise to different confor-
mational distributions within partially unfolded states with a
different ratio of a-helical/disordered structure and a variable
degree of hydrophobic interactions.
The aggregation of denatured AcP has been found to be
slow at concentrations of TFE higher than ;35% (v/v), and
AcP is predominantly in its native state at concentrations
below 18% (v/v) TFE at 25C (19). We therefore carried out
experiments in solutions having a range of TFE concen-
trations between 0% and 25% (v/v), after previously de-
stabilizing the protein by an increase in temperature or by
addition of urea. In this way, a range of different conditions
was generated in which the protein is denatured but where
noncovalent intermolecular interactions are still sufﬁciently
favorable for the formation of aggregates. The results show
that the aggregates formed from the differently structured
denatured states of AcP share similar characteristics and that,
at least in the case of AcP, the extent of a-helical structure in
the denatured state is not a critical determinant of the ability
to form amyloid ﬁbrils under speciﬁc conditions. Taken
together, these data indicate that a speciﬁc conformational
state is not required to form ordered aggregates, provided
that the solution conditions permit relatively stable inter-
molecular interactions.
MATERIALS AND METHODS
Protein production and puriﬁcation
Expression and puriﬁcation of wild-type AcP and the F94L variant were
carried out according to the procedures described previously (55). A Quik-
Change Stratagene (La Jolla, CA) kit was used for site-speciﬁc mutagenesis,
and DNA sequencing was used to ensure the presence of the desired mu-
tations. The cysteine residue at position 21 was replaced by serine to avoid
complexities arising from the presence of a free cysteine residue; the re-
sulting mutant is described here as the wild-type protein as in previous
studies (56). Protein concentrations were measured by ultraviolet (UV)
absorption using e280 values of 1.49 ml mg
1 cm1.
Aggregation kinetics
The rates of aggregation of the AcP variants were measured as previously
described (57). In brief, for each experiment 60ml aliquots of the samplewere
mixed at regular time intervals with 440 ml of 50 mM acetate buffer, pH 5.5,
25C, containing25mMThT.AVarianCaryEclipse spectroﬂuorimeter (Palo
Alto, CA) with excitation and emission wavelengths of 440 and 485 nm,
respectively, was used to determine ThT ﬂuorescence values. Single
exponential functions were ﬁtted to the kinetic plots reporting the measured
ThT ﬂuorescence versus time to determine the aggregation rate constants.
Circular dichroism
Circular dichroism (CD) spectra were recorded on a Jasco J-710 spec-
tropolarimeter (Great Dunmow, Essex, UK) equipped with a thermostated
cell holder and using a 1 mm path-length quartz cell. CD spectra were ob-
tained from aliquots withdrawn from the aggregation mixtures at the times
indicated, and spectra were measured at the indicated temperature (25C or
55C). The secondary structure content was estimated from each spectrum
by using the CDPro software package (58).
Attenuated total reﬂection Fourier transform
infrared spectroscopy
Attenuated total reﬂection Fourier transform infrared (ATR-FTIR) spectra
were recorded using a Bruker Equinox55 spectrometer (Ettlingen, Germany)
equipped with a liquid N2-cooled mercury cadmium telluride detector and
purged with a continuous ﬂow of N2 gas. A BioATRCell II accessory from
Brukerwas used as a sampling system. Spectraweremeasured at the indicated
temperature (25C or 55C). For each sample, 256 interferograms were
accumulated at a spectral resolution of 2 cm1. Buffer spectra were recorded
under identical conditions to those of the protein samples and automatically
subtracted from the spectra of the proteins using Bruker Protein Dynamics
software. Spectrawere baselined and then normalized such that theminimally
occurring y-value was set to 0 and the maximally occurring y-value to 2
absorbance units.
Transmission electron microscopy
Samples were applied to Formvar-carbon-coated nickel grids (400 mesh),
negatively stained with 2% (w/v) uranyl acetate, and viewed in a Philips
CM100 transmission electron microscope (Eindhoven, The Netherlands)
operating at 80 kV.
RESULTS
Aggregation of AcP after destabilization by heat
Solutions of AcP in 50 mM sodium acetate, pH 5.5, were
heated at 55C for 1 h. From the previously described
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thermal denaturation behavior (59), it is possible to infer that
under these conditions the native state is at least partially
populated and is in equilibrium with the denatured state.
Indeed, AcP maintains a signiﬁcant degree of activity under
these conditions. CD and ATR-FTIR spectra conﬁrm the
presence of a nonnative state populated to a signiﬁcant extent
(Figs. 1 a and 2 a). The completely unfolded state formed at
higher temperatures was found to convert rapidly into amor-
phous aggregates that lack any secondary structure elements
detectable by CD or ATR-FTIR and was therefore not stud-
ied further. TFE was added to the destabilized samples at
55C to give ﬁnal concentrations of TFE of 5%, 10%, 15%,
and 25% (v/v) and 0.4 mg/ml of AcP.
CD spectra, each representing a weighted average of an
ensemble of different conformational states, were recorded
1 min after the addition of the various concentrations of TFE
to the samples at 55C (Fig. 1 a). The extent of a-helical
structure in the partially unfolded protein was found to
increase as the concentration of TFE increases to 25% (Fig. 1
a, Table 1), in accord with previous observations on the
effect of TFE on the structural properties of AcP at lower
temperature (19). A control experiment performed at a con-
centration of protein substantially lower than 0.4 mg/ml
(0.08 mg/ml) to reduce the aggregation rate sufﬁciently to
allow measurements to be made in 5% TFE, demonstrates
that after 1 min all the structural transitions induced in the
monomeric protein at 55C are complete.
The propensity for the protein samples to form aggregates
under these conditions was assessed by using ThT, a dye
that speciﬁcally binds to ordered b-sheet aggregates and,
notably, to amyloid ﬁbrils (60). In the absence of TFE, no
increase in ThT ﬂuorescence was observed even after 60 h of
incubation at 55C (Fig. 3 a). By contrast, exponential
increases in ThT intensity were observed in the solutions to
which TFE was added (Fig. 3 a). The rates are signiﬁcantly
slower in 15% and 25% TFE than in 5% and 10% TFE (Fig.
3 a) although the ﬂuorescence intensities at the end of the
exponential phases are comparable in all the samples.
The ﬁnding that the rate of aggregation decreases as the
TFE concentration is increased from 5% to 25% (v/v) sug-
gests that an increase in a-helical structure inhibits aggre-
gation. CD spectra of the samples recorded after 1 day,
however, all show a decrease in the a-helical content and a
corresponding shift toward b-structure (shown by an in-
crease in ellipticity at ;216 nm) characteristic of aggregate
formation (Fig. 4, a and b). In addition, differences in the
ellipticity of the samples at different TFE concentrations are
due at least in part to a decrease in the intensity resulting
from scattering by the aggregated species (13).
ATR-FTIR spectra were recorded after incubation of the
solutions for 1 week under the conditions described above.
Unlike the spectra of the samples incubated at 25C or 55C
in the absence of TFE, the spectra of all the samples in 5–
25% TFE, 55C, exhibit an intense peak between 1630 and
FIGURE 1 Far-UV CD spectra of different
initial states fromwhichAcP aggregates. Spec-
tra were acquired 1 min after the addition of
different concentrations of TFE to AcP
samples preincubated at 55C (a) and in 2 M
urea at 25C (b). In b, the F94L mutant was
used instead of wild-type (wt) AcP (see text).
Black indicates the native state at 25C in the
absence of TFE and urea; the colors indicate
different TFE concentrations added to the
destabilized state at 55C or 2 M urea: blue,
0% TFE; cyan, 5% TFE; purple, 10% TFE;
red, 15% TFE; orange, 25% TFE. (c) Com-
parison of the spectra of samples at 25C
(solid line), 55C (dashed line), and in 2 M
urea, 25C (dotted line), all obtained in the
presence of 25% TFE.
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1615 cm1 in the amide I9 region, implying, in agreement
with the CD spectra, that the aggregated species possess
extensive b-sheet structure (Fig. 2 a). Signiﬁcantly, this type
of infrared spectrum has been shown to be characteristic of
amyloid ﬁbrils (71). In addition, transmission electron
microscopy (TEM) images taken after 1 week at 5%, 10%,
and 15% TFE show the presence of well-deﬁned ﬁbrillar
structures (Fig. 5, a and b) with diameters of;10 nm (Fig. 5
a, inset), consistent with the data for the majority of well-
deﬁned amyloid ﬁbrils formed by other proteins (62). At 25%
TFE the aggregates appear to be less regularly structured.
Aggregation of AcP after destabilization by
mutation and urea
The aggregates of AcP formed at a protein concentration of
0.4 mg/ml in 25% (v/v) TFE at pH 5.5 and 25C were found
to dissolve at urea concentrations higher than 2.5 M. As the
midpoint of the urea denaturation of wild-type AcP under
similar conditions of pH and temperature is ;4.5 M urea
(59), we used a destabilized mutant, F94L, to enable AcP to
be unfolded under conditions that still promote aggregation.
The aggregation rate of this mutant from the partially
unfolded state formed in 25% TFE has been found to be very
similar to that of the wild-type protein (19), and CD analysis
conﬁrms that F94L AcP is unfolded in 2 M urea in the
absence of TFE (Fig. 1 b, Table 1). Samples of F94L AcP
were therefore incubated in 2 M urea, 50 mM sodium
acetate, pH 5.5, 25C for 1 h to ensure unfolding was
complete. Different concentrations of TFE were then added
to obtain solutions of 0.4 mg/ml of protein in 2 M urea
containing 5%, 10%, 15%, and 25% (v/v) TFE. The CD
spectrum acquired after 1 min after the addition of 5% TFE is
very similar to that of the unfolded sample in the absence of
TFE (Fig. 1 b), but there is a progressive increase in the
extent of a-helical structure as TFE concentration is
increased to 10%, 15%, and 25% (Fig. 1 b, Table 1).
The kinetics of aggregation under these conditions was
again measured using ThT ﬂuorescence (Fig. 3 b). In the
absence of TFE, no aggregation was observed for more than
1 week, whereas in its presence aggregation is almost com-
plete at all the concentrations examined here (Fig. 3 b).
FIGURE 2 ATR-FTIR spectra of different aggregated
states of AcP. Amide I9 spectra were acquired 1 week after
the addition of different concentrations of TFE to samples
preincubated at 55C (a) and in 2 M urea at 25C (b). In b,
the F94L mutant was used instead of wt AcP. The color
code is the same as in Fig. 1. Spectra were normalized to
the minimum and maximum absorbance values in each
experiment.
TABLE 1 Comparison of secondary structure content* before aggregation and half time for the aggregation reactiony
% a-helix % b-sheet % turn % random t½ (min)
wt 0%TFE 25C 20.3 6 5.0 31.4 6 5.0 19.9 6 5.0 28.4 6 5.0
wt 25%TFE 25C 43.0 6 5.0 11.4 6 5.0 15.9 6 5.0 29.7 6 5.0 9 6 3§
wt 0%TFE 55C 18.4 6 5.0 30.0 6 5.0 20.1 6 5.0 31.5 6 5.0
wt 5%TFE 55C 20.7 6 5.0 26.9 6 5.0 21.4 6 5.0 31.0 6 5.0 51 6 5
wt 10%TFE 55C 17.5 6 5.0 26.8 6 5.0 19.6 6 5.0 36.1 6 5.0 45 6 5
wt 15%TFE 55C 19.3 6 5.0 22.5 6 5.0 18.9 6 5.0 39.3 6 5.0 230 6 10
wt 25%TFE 55C 33.6 6 5.0 14.3 6 5.0 19.6 6 5.0 32.5 6 5.0 1430 6 60
F94L 0%TFE 2 M ureaz 25C 6.9 6 5.0 16.7 6 5.0 11.2 6 5.0 65.2 6 5.0
F94L 5%TFE 2 M ureaz 25C 7.1 6 5.0 16.8 6 5.0 11.3 6 5.0 64.8 6 5.0 3540 6 120
F94L 10%TFE 2 M ureaz 25C 7.3 6 5.0 18.6 6 5.0 10.5 6 5.0 63.6 6 5.0 2520 6 90
F94L 15%TFE 2 M ureaz 25C 17.5 6 5.0 15.5 6 5.0 13.1 6 5.0 53.9 6 5.0 1230 6 60
F94L 25%TFE 2 M ureaz 25C 35.6 6 5.0 13.3 6 5.0 18.0 6 5.0 33.1 6 5.0 1920 6 75
*Obtained using the CDPro software package (58). An error of 6 5.0 is estimated for each value.
yExpressed as half times of the maximum value of the ﬂuorescence intensity obtained within the timescale shown in Fig. 3.
zThe effect on the spectra at wavelengths lower than 210 nm resulting from the presence of urea allows only a qualitative estimate of the secondary structure
content to be made.
§Values extrapolated from Chiti et al. (57).
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Compared to the aggregation process followed at 55C in the
absence of urea, the kinetics of aggregation in urea at 25C
are dramatically slower at equivalent concentrations of TFE
(Fig. 3). In addition, aggregation in urea proceeds with
nonexponential kinetics, and at 5% TFE a well-deﬁned lag
phase is clearly evident. This lag phase becomes shorter as
the TFE concentration is increased (Fig. 3 b). Lag phases are
commonly observed in aggregation reactions and indicate
the need for a nucleation step before the rapid growth phase.
The lack of a lag phase for AcP aggregation under most con-
ditions indicates that the nucleation process is not rate deter-
mining. The fact that there is a lag phase for the aggregation
of the F94L mutant in the presence of urea suggests that
nucleation is now rate determining for this AcP variant,
perhaps because the stability of the initial oligomers is de-
creased under these conditions.
After 1 week of incubation, a decrease in intensity was
observed in the CD spectra of the sample incubated in 5%
TFE, whereas a clear shift from a typically a-helical to a
b-sheet spectrum was found for the samples incubated at
higher TFE concentrations (Fig. 4, c and d). Analysis of
these samples using ATR-FTIR shows spectra very similar
to those observed for the samples incubated at 55C, with an
intense peak at;1615 cm1, indicative of a high b-structure
content in the protein aggregates (Fig. 2 b). However, in the
presence of only 5% TFE, a strong peak at;1650 cm1 and
the lack of intensity at 1665 cm1, attributable to turn
structures, indicate that the protein is largely unstructured
FIGURE 3 Aggregation kinetics of AcP
from different partially unfolded states. Aggre-
gation was monitored by ThT ﬂuorescence
after the addition of different concentrations of
TFE to samples preincubated at 55C (a) and in
2 M urea, 25C (b). In b, the F94L mutant was
used instead of wt AcP. The color code is the
same as in Fig. 1. The data points were nor-
malized to attribute 100% intensity to the max-
imum value of ThT ﬂuorescence intensity
observed at the end of each experiment. The
solid lines in a represent the single exponential
functions which provide the best ﬁts to the data.
FIGURE 4 Far-UV CD spectra of AcP
before and after aggregation. Spectra were
acquired after 1 min (solid line), 1 day (dotted
line, a and b), or 1 week (dotted line, c and d)
after the addition of different concentrations
of TFE to samples preincubated at 55C (a
and b) and in 2 M urea (c and d). In c and d,
the F94L mutant was used instead of wt AcP.
The samples were incubated in 5% (a), 10%
(c), 15% (b), and 25% (d) TFE. A similar shift
of the peak to wavelengths between 210 and
220 nm was observed also for the samples
incubated in 15–25% TFE at 55C, and
5–10% TFE in 2 M urea.
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under these conditions. Despite the relatively high content of
b-structure and the ability to bind to ThT, the aggregates
formed in higher concentrations of TFE (10–25%) do not
have the typical morphology of amyloid ﬁbrils, although
a form of ﬁlamentous structure is suggested by TEM images
of samples incubated for 1 week (Fig. 5 c).
Effects of heat and urea on the monomeric
precursors to aggregate formation
Since elevated temperature and the presence of urea per-
turb intramolecular as well as intermolecular interactions, a
detailed comparison of the aggregation process at the same
TFE concentrations under these different conditions is un-
likely to be meaningful. It is possible, however, to compare
the CD spectra of partially unfolded AcP in 25% TFE under
these different conditions. Comparison of the species pres-
ent in 25% TFE at 25C and 55C shows that the extent of
a-helical structure is signiﬁcantly greater in the samples at
25C than at 55C, indicating that hydrogen bonding is less
dominant at higher temperatures (Fig. 1 c, Table 1). The CD
spectrum of the F94L mutant of AcP after 1min in 25% TFE,
25C, 2 M urea, shows an a-helical content lower than that
of wild-type AcP under the same conditions in the absence
of urea but slightly higher than that found at 55C in the
absence of urea (Fig. 1 c, Table 1). Under the former condi-
tions, however, aggregation is dramatically slower, indicat-
ing the absence of a straightforward correlation between
aggregation rate and a-helical content within the initial
conformational state. This result indicates also that urea is
likely to destabilize the formation of hydrogen bonds.
Both heat and urea are also likely to affect the strength of
the hydrophobic effect on intermolecular interactions. A
rough comparison of the half times (t1/2) of the maximum
values of ﬂuorescence intensity obtained within the timescale
used here with respect to the concentration of TFE results in
the order 0  5 ; 10 , 15 , 25% TFE for experiments
carried out at 55C and 0  5 . 10 . 15 , 25% TFE for
experiments carried out in 2 M urea, 25C (Table 1). The fact
that the minimum t1/2 of aggregation is 5% TFE at 55C but is
15% TFE in 2 M urea, 25C, and the ﬁnding that changes in
hydrophobicity through mutations can inﬂuence the aggrega-
tion rate of a polypeptide (57), suggest that this shift could be
due to a larger decrease in the hydrophobic effect in urea
rather than to the changes in temperature.
DISCUSSION
Solution conditions are critical for aggregation
Partial or complete unfolding of the native state of AcP is not
by itself sufﬁcient to promote aggregation during the re-
latively short timescale used here (1 week). Under conditions
where the protein is partially (55C) or effectively com-
pletely unfolded (2 M urea) the protein does not aggregate at
a signiﬁcant rate in the absence of TFE. This result can be
rationalized by considering that denaturant conditions that
are strong enough to unfold the protein substantially, such as
high temperature or addition of urea, not only destabilize
intramolecular interactions but also the analogous intermo-
lecular interactions. Thus, weaker hydrophobic interactions
are likely to result both in reduced compactness and in-
creased solubility.
Under such conditions, the addition of TFE (a solvent less
polar than water and a weaker hydrogen bond competitor)
appears to promote the formation of ordered aggregates by
strengthening the interactions that stabilize intermolecu-
lar b-sheet structure as well as intramolecular b-turns and
helical structure (43,48,53,63). We can therefore conclude
that under the conditions used here, the formation of inter-
molecular hydrogen bonds is likely to be an important driv-
ing force for the aggregation of denatured AcP. The effect of
TFE at concentrations ranging from 5% to 25% is therefore
to change the balance of factors that favor aggregation rel-
ative to solubility and to provide an environment which
favors strong intermolecular interactions.
If the extent of a-helical structure present in the partially
unfolded state reﬂects the degree to which intramolecular
peptide hydrogen bonds are stabilized under different con-
ditions, then high temperatures and addition of urea both
weaken the strength of hydrogen bonds as shown in Fig. 1 c.
To aggregate, a protein such as AcP requires at least partial
unfolding to expose the polypeptide main chain and hydro-
phobic residues to enable strong intermolecular interactions
to develop; the compact native states of globular proteins
have been selected by evolution to avoid aggregation pri-
marily by the burial of their hydrophobic groups and the
FIGURE 5 Aggregates of AcP observed by TEM. The
protein was incubated in 5% (a) and 15% TFE (b) at 55C
or in 10% TFE and 2 M urea at 25C (c), and images were
acquired after 1 week. In c, the F94L mutant was used
instead of wt AcP. An expanded image is shown in the
inset (a). The scale bars at the bottom of a and c correspond
to 100 nm; those in b and in the inset correspond to 50 nm
and 10 nm, respectively.
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judicious placement of charged and polar residues on the
surface (1). Importantly, the observation that aggregation
often occurs from a partially, rather than fully, unfolded state
does not indicate that the presence of residual structure is
important to promote amyloid aggregation. Rather, the struc-
ture present in the partially unfolded state may simply be a
consequence of the fact that the solution conditions promot-
ing aggregation are also those that will stabilize intramolec-
ular (often native-like) structure as the types of interactions
involved in the two processes are essentially identical. This
observation suggests, therefore, that the nature of the struc-
ture of the initial conformational state may be of much less
importance than factors such as hydrophobicity, net charge,
and b-sheet propensity (35).
Very different initial states can result in very
similar aggregated states
In this study, we were able to generate aggregation-prone
partially unfolded states of AcP with very different secondary
structure contents by variation of the solution conditions.
The essential nature of the resulting amyloid-like aggregates
(ﬁbrillar morphology, extensive b-structure, and ThT bind-
ing) is preserved although the exact details of the inter-
molecular interactions undoubtedly differ with the conditions.
Examination of the literature provides further evidence for
this conclusion. For example, the protein lysozyme has been
shown to be able to form amyloid ﬁbrils that appear to be
closely similar under many different conditions, including
the presence of denaturants such as guanidine hydrochloride
(64) and ethanol (65), application of hydrostatic pressure
(23), reduction of disulﬁde bonds (66), partial proteolytic
degradation (67), low pH values, and high temperatures (21).
As in this study, however, the partially unfolded states from
which aggregation is initiated have rather distinct structural
characteristics that are becoming increasingly evident from
the ability to carry out detailed studies of nonnative states of
proteins (68,69).
The formation of both ﬁbrillar and nonﬁbrillar aggre-
gates, each of which can have a high content of b-sheet struc-
ture, appears from the results of this study to be substantially
independent of the overall initial secondary structure con-
tent. As shown schematically for AcP in Fig. 6, the initial
monomeric species can posses a mixture of a-helical and
b-sheet character (5% TFE, 55C) or be rich in a-helical
(25% TFE, 55C) or highly disordered (F94L mutant, 10%
TFE, 2 M urea) structure. These results also demonstrate that
the presence of a particular type of secondary structure is
not mandatory for the aggregation process of AcP to give rise
to amyloid ﬁbrils. An increase of TFE concentration from
5–10% to 15–25% at 55C results in an increase in a-helical
structure and a slower aggregation process; the latter can be
attributable to the fact that a-helices involve intramolecular
hydrogen bonds and therefore their presence reduces the
probability of forming intermolecular interactions. In sup-
port of this conclusion, it has been shown that mutations in
proteins that stabilize a-helical structure can slow down the
process of aggregation from their denatured states (70,71).
Despite such considerations, the regions of a polypeptide
sequence involved in triggering the aggregation process from
very different initial states could well differ signiﬁcantly.
These regions are in general likely to be those that are
relatively ﬂexible and not involved in strong intramolecular
interactions (18,22,72–74). Interestingly, the regions of the
sequence of AcP in 25% TFE found to be exposed to solvent
from limited proteolysis studies match those previously
identiﬁed to be critical in the rate-determining steps of ag-
gregation from protein engineering approaches (39,57).
Nevertheless, different conditions may cause different regions
to have such characteristics and therefore to be those that
initiate the aggregation process. In addition, it has been
shown that speciﬁc features of the amino acid sequence, as
well as the solution conditions, can signiﬁcantly inﬂuence
the aggregation rate (35,75,76). Such considerations can
explain, at least in part, why partially unfolded states of AcP
formed under very different conditions have very different
aggregation rates. In accord with previous studies, the
different precursor states that result from different solution
conditions can generate ﬁbrillar or nonﬁbrillar aggregates
with similar b-sheet content but with distinct morphological
features, for example ﬂat ribbons as compared to more
cylindrical forms of amyloid ﬁbrils (34,77). One contribution
to such effects could be that different parts of the protein
are involved in the dominant intermolecular interactions
under the different conditions. Thus, even when interactions
involving the polypeptide backbone are the major determi-
nants of amyloid structure through the formation of inter-
molecular hydrogen bonds, the side chains can still exert a
signiﬁcant inﬂuence on the features of the resulting assembly
FIGURE 6 Schematic representation of the aggregation process of AcP
from different partially unfolded states. The globular native state of AcP is
converted into a partially unfolded state that can contain a mixture of
a-helical and b-sheet structure (5% TFE, 55C), a high content of a-heli-
cal (25% TFE, 55C) or disordered (F94L, 10% TFE, 2 M urea, 25C) struc-
ture. Despite the differences in the conditions, all of these partially unfolded
states can be converted into ordered ﬁbrillar aggregates containing a highly
organized b-sheet structure.
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(10,34,35). Although much remains to be learned about the
way that side-chain interactions and solution conditions
inﬂuence the morphology of the aggregates, a more profound
understanding of the basic principles that underlie the pro-
cess of protein aggregation will undoubtedly shed further
light both on this issue and on related phenomena, such as
the way in which the details of protein aggregation can con-
tribute to human disease and its treatment.
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